NDAINTRAVENOUSSOLUTION
Approved
Feb 2023
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREVDUO is a fixed-dose intravenous combination of neostigmine methylsulfate (an acetylcholinesterase inhibitor) and glycopyrrolate (an anticholinergic agent) approved in February 2023. It is indicated for reversal of neuromuscular blockade in patients undergoing surgery. The combination works by inhibiting acetylcholinesterase to increase acetylcholine availability while glycopyrrolate prevents muscarinic side effects.
Peak12.2 years to LOE
Product is in peak commercial phase as a recently approved IV agent in a procedure-based indication; commercial team size likely established but expansion opportunities limited by indication scope.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PREVDUO represents a stable, specialized opportunity in the procedural/hospital formulary space with minimal current job activity but predictable, long-term commercial demand. Career growth is moderated by indication specificity but supported by strong patent protection and procedure-based utilization patterns.
Hospital Account ManagerPerioperative Field Sales Representative
Worked on PREVDUO at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.